X

Pharmaceutical

Medico Remedies Q4FY23 Earnings Story

Medico Remedies is engaged in the business of Manufacture of allopathic pharmaceutical preparations. Financial Results: Medico Remedies Limited reported Total…

Neuland Laboratories Q4FY23 Earnings Story

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial…

Orchid Pharma Limited Q4FY23 Earnings Story

Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage…

Lupin Limited Q4FY23 Earnings Story

Lupin manufactures pharmaceuticals as a line of business. Globally, APIs, biotechnology products, and generic formulations are all developed and marketed…

Syngene International Ltd (SYNGENE) Q4 FY23 Earnings Concall Transcript

Syngene International Ltd (NSE:SYNGENE) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Avantika Mishra -- Investor Relations Jonathan Hunt -- Managing Director…

Panacea Biotec Limited: Making India Healthier

Panacea Biotec Limited is an Indian pharmaceutical company that is engaged in research, development, and manufacturing of pharmaceuticals, vaccines, and…

Can Jubilant Pharmova leverage their position?

“In FY24, Company’s profitability is expected to improve, driven by growth in Radiopharmaceuticals, Allergy Immunotherapy and CDMO Sterile Injectables businesses.…

Glenmark Pharmaceuticals: An Uphill Battle

“Strategic priority is to enhance our free cash generation and further debt reduction and we continue discussion with potential partners…

Sun Pharma Advanced Research Q3FY23 Earnings

(SPARC) Sun Pharma Advanced Research Company Limited conducts pharmaceutical product research and development (R&D). Financial Results: After nine consecutive quarters…

Shilpa Medicare Limited Q3FY23 Earnings

With cutting-edge technology, Shilpa Medicare is in the business of manufacturing high-quality Active Pharmaceutical Ingredients, Intermediates, Formulations, Novel Drug delivery…

Sanofi India Limited Q3FY23 Earnings Story

Sanofi India primarily deals with the Manufacture and sale of pharmaceutical products. Financial Results: The company reported a decline of…

Procter & Gamble Health Q2FY23 Earnings Story

Procter & Gamble Health Ltd. primarily deals with both manufacturing and marketing various chemicals and pharmaceuticals. Financial Results: Procter &…

NATCO Pharma Limited Q3FY23 Earnings

A pharmaceutical firm with a strong focus on research and development, NATCO Pharma Ltd creates, produces, and markets sophisticated pharmaceuticals…

Pfizer Limited Q3FY23 Earnings Story

Pfizer Ltd is primarily involved in marketing, exporting, manufacturing, and trading of pharmaceutical products. It produces goods through its in-house…

Panacea Biotec Q3FY23; 26% Fall in Revenue

Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937…

Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript

Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director,…

Lupin Limited Q3FY23; 47% Growth in Profits

Lupin Limited’s revenue in Q3FY23 rose 13% to ₹ 1,97,66,301 lakhs. Consolidated Profit After Tax came at ₹ 8,34,871 lakhs…

Sun Pharmaceutical Q3FY23; 3% Growth in Profits

Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹…

Aurobindo Pharma Q2FY23; 41% Fall in Profits

Aurobindo Pharma Ltd.‘s revenue in Q2FY23 fell 3% to ₹ 5,739 crores. Consolidated Profit came at ₹ 409 crores showcasing…

Divi’s Laboratories Q2FY23; 19% Fall in Profits

Divi's Laboratories Ltd.'s revenues in Q2FY23 fell 7% to ₹ 1,855 crores. Consolidated Profit came at ₹ 494 crores showcasing…

Torrent Pharmaceuticals Limited Q2FY23; Profits down by 1%

Torrent Pharmaceuticals Ltd.‘s Revenues for Q2 FY23 has increased by 7% YoY to ₹ 2,291 crores. Net Profit fell by…